U.S. Markets
Eli Lilly (LLY) begins construction on a USD 3.5bln site in Pennsylvania’s Lehigh Valley to produce next-generation obesity drugs, its tenth new US site since 2020
ORIGINAL · NewsquawkEli Lilly (LLY) begins construction on a USD 3.5bln site in Pennsylvania’s Lehigh Valley to produce next-generation obesity drugs, its tenth new US site since 2020
StockNow breaking-news AI analysis
Lilly’s Lehigh Valley project is its tenth new U.S. site since 2020.
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
